跳至主要内容
临床试验/ITMCTR1900002563
ITMCTR1900002563尚未招募4 期

Study for the effect of Danlou tablet on gut microbiota of CHD patients and its metabolomics

Traditional Chinese Medicine Hospital of Tailai County, Qiqihar City, Heilongjiang Province0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Basic Science

入排标准

性别
All

入选标准

  • 1. Aged between 40-85 years;
  • 2. Meets the diagnostic criteria for stable coronary heart disease;
  • 3. singed the consent form.

排除标准

  • 1. Combined with Congenital heart disease, rheumatic heart disease, unstable angina pectoris;
  • 2. Combined with Valvular disease, suspected major artery dissection, arrhythmia, acute heart failure, moderate to severe pulmonary hypertension, acute pulmonary embolism and other serious cardiopulmonary dysfunction;
  • 3. Combined with Severe liver and kidney dysfunction, immune diseases;
  • 4. Combined with acute infection;
  • 5. Patients who used antibiotics, other lipid-lowering and blood-glucose lowering drugs and other Chinese medicines before 2 weeks and during the experiment;
  • 6. Involuntary patients, poor compliance;
  • 7. Participated in other clinical trials.

研究者

发起方
Traditional Chinese Medicine Hospital of Tailai County, Qiqihar City, Heilongjiang Province

相似试验